Ignite Creation Date:
2025-12-24 @ 9:54 PM
Ignite Modification Date:
2026-01-16 @ 7:38 PM
Study NCT ID:
NCT01462032
Status:
COMPLETED
Last Update Posted:
2014-06-04
First Post:
2011-09-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Non-pharmacological Interventions for Preschoolers With Attention Deficit Hyperactivity Disorder (ADHD)
Sponsor:
Queens College, The City University of New York
Organization:
Study Overview
Official Title:
Training Executive, Attention, and Motor Skills (TEAMS): Preliminary Studies
Status:
COMPLETED
Status Verified Date:
2014-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NIPA
Brief Summary:
This study is designed to evaluate two potential treatments for children with Attention-deficit/Hyperactivity Disorder (ADHD) that do not involve the use of medication. Our goal is to develop new interventions for preschoolers with ADHD that will result in enduring reductions of ADHD symptoms and associated impairments in children, and thus prevent long-term difficulties characteristic of many children with ADHD.
Both interventions involve weekly playgroups (of roughly five children) in which children engage in designated activities while parents engage in groups focusing on parent education, support, and their children's activities. It is hypothesized that both interventions will be helpful, but that only one will have lasting effects well beyond the end of active treatment.
Both interventions involve weekly playgroups (of roughly five children) in which children engage in designated activities while parents engage in groups focusing on parent education, support, and their children's activities. It is hypothesized that both interventions will be helpful, but that only one will have lasting effects well beyond the end of active treatment.
Detailed Description:
Children eligible for this study are:
* 4 and 5 years-old (between the ages of 48 - 72 months)
* shows signs and symptoms of hyperactivity, impulsiveness and/or inattention. To enter the study, following our evaluation, they will need to meet diagnostic criteria for ADHD
* enrolled in a preschool or daycare setting
Children are ineligible to participate in this study if they:
* are currently being treated with psychotropic medication
* have a diagnosed neurological disorder
* have an autism spectrum pr pervasive developmental disorder
* are intellectually impaired
* are highly physically aggressive
* 4 and 5 years-old (between the ages of 48 - 72 months)
* shows signs and symptoms of hyperactivity, impulsiveness and/or inattention. To enter the study, following our evaluation, they will need to meet diagnostic criteria for ADHD
* enrolled in a preschool or daycare setting
Children are ineligible to participate in this study if they:
* are currently being treated with psychotropic medication
* have a diagnosed neurological disorder
* have an autism spectrum pr pervasive developmental disorder
* are intellectually impaired
* are highly physically aggressive
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: